Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Ruan, D
Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: a guide to management for the advanced practitioner
Quick Takeaways Tesamorelin has robust clinical evidence for reducing visceral fat (15-17.5%), increasing lean mass (1.42 kg), and improving metabolic markers in human trials Ipamorelin selectively releases growth hormone without affecting cortisol or prolactin, making it the cleanest GHRP available Combining a GHRH with a GHRP creates synergistic GH pulsatility that mimics and amplifies your bodys natural growth hormone patterns My recommended protocol: Tesamorelin 1mg + Ipamorelin 100mcg, injected AM/PM, 5 days on/2 days off, 8 weeks on/8 weeks off What This Peptide Combination Actually Is Tesamorelin and Ipamorelin target different receptors in the growth hormone regulation system, which is precisely why they work so well together
References Pizzorno J
Rabinovsky et al
European Journal of Clinical Pharmacology, 1992
